Navigation Links
Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
Date:2/3/2009

igel (www.Rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains forward-looking statements, including, but not limited to, statements related to the potential efficacy of R788, enrollment rate in clinical trials of R788, Rigel's plans to pursue clinical development of its product candidates, including R788, the market opportunity for its product candidates, expansion of and changes in its product portfolio, Rigel's plans to pursue collaboration partnerships for product candidates, the estimated charge related to the workforce reduction, the sufficiency of Rigel's cash and cash equivalents to fund current and projected development and operating plans, and Rigel's cash and cash equivalent balance at December 31, 2009. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Rigel's actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the development of Rigel's product candidates, including risks related to the timing and success of clinical trials, and potential problems that may arise in the clinical testing and approval process, and
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
2. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
3. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
5. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
6. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
7. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
8. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
9. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
10. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 The western European automated endoscope ... largely a replacement market with fewer new installations ... and partnerships are redefining competitive landscape in western ... provides details about revenue forecasts, unit shipments, market ... the country. The changing landscape makes it important ...
(Date:9/22/2014)... , Sept. 22, 2014 Research and ... Market for Neurotechnology: 2014-2018" report to their offering. ... is the most comprehensive and up-to-date publication available covering ... at the technology, markets, competitors, and growth rates in ... years 2014 through 2018. It forecasts the number of ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s ... of Monday, Sept. 29 at 5 p.m. EDT ... Kids!" competition, in response to continued strong interest ... $50,000 each will be awarded to the winning ... Surgical Innovation Symposium hosted by Children,s National in ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3The Market for Neurotechnology: 2014-2018 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3
... 14, 2011 OCuSOFT, Inc., an ophthalmic pharmaceutical research, ... agreement with Ardeo Health, LLC to distribute a novel ... of Evry, France, Nova23041. Nova23041 will be ... as Retaine® MGD™ Ophthalmic Emulsion under a brand license ...
... Better Health ™, a program of Lilly USA, LLC, ... healthier, more active lives, launches an enhanced multi-channel platform ... health information. The platform includes an array of patient ... manage their health, a dynamic website – lillyforbetterhealth.com ...
Cached Medicine Technology:Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT® 2Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT® 3Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform 2Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform 3
(Date:9/22/2014)... 22, 2014 The Philadelphia 100, which ... Philadelphia region each year, is considered a hallmark of ... MK Precision is proud to announce it has earned ... Precision will attend the Philadelphia 100 awards ... premiere business events of the year, as well as ...
(Date:9/22/2014)... Mich. A surprising new study pulls back the ... health care: differences in payment and income between physicians ... don,t. , Contrary to perception, the research indicates, ... favor surgeons and other procedure-performing doctors. , The new ... difference in pay per minute explains why doctors who ...
(Date:9/22/2014)... By Alan Mozes ... -- Pediatricians, take note: Many American parents are aware of ... to choose a pediatrician for their children, according to a ... from more than 1,600 parents -- further suggest that negative ... if that doctor has been recommended by a neighbor. ...
(Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
(Date:9/22/2014)... researchers have published a pilot study showing the ... people with multiple sclerosis (MS). Improvements were ... and pain. "Development and effectiveness of a ... Description and outcomes" was epublished ahead of print ... of MS Care (doi: 10.7224/1537-2073.2013-045). The authors ...
Breaking Medicine News(10 mins):Health News:MK Precision Announces Spot on Philadelphia 100 Fastest Growing Companies 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2
... of Healthcare Startup, NEW YORK, Aug. 19 ... book doctor appointments online, today announced it has,completed ... led by Khosla Ventures.,ZocDoc is the first consumer ... http://www.newscom.com/cgi-bin/prnh/20080819/LATU010LOGO ), ZocDoc uses the Internet to ...
... today a 3-year agreement with Aetna (AET) that will ... metro markets in,Florida, Texas and Georgia., "Aetna long ... and,advocacy for timely and appropriate end-of-life care, with programs ... Innovative Hospice,Care. "As a hospice pioneer and innovator, VITAS ...
... Mental, Physical And Behavioral ... Performance In School-age Children, CABOT, Vt., Aug. 19 Who ... with a healthy breakfast? Apparently more folks,than you might ever imagine. ... and 32 percent of boys who are,of school age, skip breakfast ...
... Coverage for Wheelchairs,Oxygen, and Other Home Medical Equipment and ... out of,four (74 percent) American voters agree that, "home ... rapidly increasing Medicare spending for,America,s seniors." Voters age 55-plus ... national telephone survey of 1,000 American adults conducted by,Harris ...
... years as an industry leader in successful medical practice management ... ... August 19, 2008 -- http://www.hollanderconsultants.com [Hollander Consultants] was ... has focused on delivering consulting and training services to doctors ...
... August 19, 2008 Men with signs of benign ... dose of erectile dysfunction drug tadalafil (Cialis) to relieve ... new study published in the October 2008 issue of ... University of Texas Southwestern Medical Center at Dallas, Northwestern ...
Cached Medicine News:Health News:Khosla Ventures Into Healthcare With ZocDoc 2Health News:VITAS Innovative Hospice Care Signs Agreement with Aetna 2Health News:VITAS Innovative Hospice Care Signs Agreement with Aetna 3Health News:Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year 2Health News:Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year 3Health News:Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year 4Health News:Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year 5Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 2Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 3Health News:Hollander Consultants Celebrates 25 Years as an Industry Leader in Successful Medical Practice Management Consulting 2Health News:Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 2
Shoulder Subluxation Inhibitor (SSI) is an ideal bracing system to keep athletes on the field by reducing the risk of shoulder injury. The SSI is the only brace that allows TOTAL ANTERIOR RANGE OR MO...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... single size, the Sierra Universal Collar fits the ... the comfort and motion restriction needed to protect ... the right size for the right fit . ... size and compact design alleviate storage problems, the ...
... spinal bracing is a critical component of ... stabilization. The Aspen® Lumbosacral Bracing System™ offers ... a high degree of immobilization, unparalled comfort, ... . . . even if they gain ...
Medicine Products: